Beijing Gobroad Hospital
Clinical trials sponsored by Beijing Gobroad Hospital, explained in plain language.
-
New hope for rare cancer: experimental drug targets advanced tumors
Disease control Not yet recruitingThis study tests a new drug called SHR-A1904 in people with advanced neuroendocrine carcinoma that has worsened after standard treatment. About 23 participants will receive the drug to see if it shrinks tumors and how safe it is. The goal is to control the disease, not cure it.
Phase: PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 17, 2026 08:54 UTC
-
Engineered immune cells take on advanced stomach cancer in new trial
Disease control Not yet recruitingThis early-phase trial is testing a new treatment called CT0494BCP for people with advanced stomach or gastroesophageal junction cancer that has not responded to at least two prior treatments. The therapy uses specially engineered immune cells (CAR-T cells) designed to attack the…
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Can a daily pill keep lymphoma away after CAR-T?
Disease control Not yet recruitingThis study looks at whether taking zanubrutinib (a pill) after CAR-T cell therapy can help keep non-Hodgkin B-cell lymphoma under control for longer. About 40 adults who have already had or are about to have CAR-T therapy will take zanubrutinib and be followed for 2 years. The go…
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC